Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.65 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | RGS12 | O14924 | 1/20 | 0.60 |
| ▸ | GLA | P06280 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | HTR2A | P28223 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL765762 | 1.00 | KDM4E (0.65) | KDM4ELMNAADRA2CADRA2AHIF1A | |
| SCHEMBL2736710 | 1.00 | KDM4E (0.65) | KDM4ELMNAADRA2CADRA2AHIF1A | |
| SCHEMBL9504694 | 0.97 | KDM4E (0.62) | KDM4ELMNAADRA2CADRA2AHIF1A | |
| Hydrochloric Acid SCHEMBL29430219 | 0.97 | ALDH1A1 (0.67) | KDM4ELMNAADRA2CADRA2AHIF1A | |
| SCHEMBL9504702 | 0.97 | KDM4E (0.62) | KDM4ELMNAADRA2CADRA2AHIF1A | |
| Alcohol SCHEMBL9255166 | 0.91 | KDM4E (0.57) | KDM4ELMNAADRA2CADRA2AHIF1A | |
| SCHEMBL19757666 | 0.85 | CYP3A4 (0.58) | KDM4ELMNAADRA2CADRA2AHIF1A | |
| SCHEMBL17878528 | 0.85 | CYP3A4 (0.58) | KDM4ELMNAADRA2CADRA2AHIF1A | |
| SCHEMBL6839350 | 0.85 | KDM4E (0.46) | KDM4ELMNAADRA2CADRA2AHIF1A | |
| SCHEMBL21473258 | 0.84 | KDM4E (0.60) | KDM4ELMNAADRA2CADRA2AHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228504-A1 | SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME | ARBUTUS BIOPHARMA CORPORATION (CA) | 2024-07-11 | — | — | US | disclosed |
| WO-2023234427-A1 | ANTIBODY-MULTIDRUG CONJUGATE PRECURSOR AND SYNTHETIC INTERMEDIATE THEREOF | ＵＢＥ株式会社 | 2023-12-07 | — | — | WO | disclosed |
| US-20230192671-A1 | COMPOUNDS FOR THE TREATMENT OF SARS | PURDUE RESEARCH FOUNDATION | 2023-06-22 | — | — | US | disclosed |
| US-20230192671-A1 | COMPOUNDS FOR THE TREATMENT OF SARS | PURDUE RESEARCH FOUNDATION | 2023-06-22 | — | — | US | disclosed |
| EP-4186529-A1 | IMPROVED ANTIBODY-PAYLOAD CONJUGATES (APCS) PREPARED BY SITE-SPECIFIC CONJUGATION UTILIZING GENETIC CODE EXPANSION | Veraxa Biotech GmbH (DE) | 2023-05-31 | — | — | EP | disclosed |
| WO-2023077643-A1 | CHIRAL MULTIDENTATE LIGAND AND USE THEREOF IN ASYMMETRIC HYDROGENATION | 凯特立斯（深圳）科技有限公司 | 2023-05-11 | — | — | WO | disclosed |
| US-20230124576-A1 | CHIRAL MULTIDENTATE LIGAND, AND APPLICATION THEREOF IN ASYMMETRIC HYDROGENATION | SHENZHEN CATALYS TECHNOLOGY CO., LTD (CN) | 2023-04-20 | — | — | US | disclosed |
| EP-4129335-A1 | ANTI-C-MET ANTIBODY-DRUG CONJUGATE AND APPLICATIONS THEREOF | RemeGen Co., Ltd. (CN) | 2023-02-08 | — | — | EP | disclosed |
| US-10941134-B2 | AMPK-activating heterocyclic compounds and methods for using the same | RIGEL PHARMACEUTICALS, INC. (US) | 2021-03-09 | — | — | US | disclosed |
| EP-2791142-B1 | COMPOUNDS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS | US HEALTH (US) | 2019-07-03 | — | — | EP | disclosed |
| US-20040063756-A1 | 2-Aminoquinolines as melanin concentrating hormone receptor antagonists | ABBVIE INC. | 2004-04-01 | — | — | US | disclosed |
| EP-0780157-B1 | Ruthenium complex with chiral bidentate phosphinoxazolin ligands for the enantioselective transfer hydrogenation of prochiral cetons | BASF AG (DE) | 2002-04-03 | — | — | EP | disclosed |
| EP-0977549-A1 | PERFUMES HAVING ODOR LONGEVITY BENEFITS | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-09 | — | — | EP | disclosed |
| EP-0922083-A2 | AUTOMATIC DISHWASHING DETERGENTS COMPRISING $g(b)-KETOESTER PRO-FRAGRANCES | THE PROCTER & GAMBLE COMPANY (US) | 1999-06-16 | — | — | EP | disclosed |
| WO-1998047478-A1 | PERFUMES HAVING ODOR LONGEVITY BENEFITS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | disclosed |
| EP-0564924-B1 | 2-Oxoethyl derivatives as immunosuppressants | BAYER AG (US) | 1998-09-09 | — | — | EP | disclosed |
| WO-1998007812-A2 | AUTOMATIC DISHWASHING DETERGENTS COMPRISING β-KETOESTER PRO-FRAGRANCES | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-26 | — | — | WO | disclosed |
| US-5686424-A | FOR TREATING INFLAMMATION | MILES INC. (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0780157-A1 | Ruthenium complex with chiral bidentate phosphinoxazolin ligands for the enantioselective transfer hydrogenation of prochiral cetons | BASF AKTIENGESELLSCHAFT (DE) | 1997-06-25 | — | — | EP | disclosed |
| EP-0564924-A2 | 2-Oxoethyl derivatives as immunosuppressants | Bayer Corporation (US) | 1993-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063756-A1 | 2-Aminoquinolines as melanin concentrating hormone receptor antagonists | MCHR1, MCHR2, MC1R | KDM4E 808/4885LMNA 3870/4885ADRA2C 100/4885 |
| US-20230124576-A1 | CHIRAL MULTIDENTATE LIGAND, AND APPLICATION THEREOF IN ASYMMETRIC HYDROGENATION | H1-4, CHRM1, CHRM2 | KDM4E 1081/4885LMNA 1366/4885ADRA2C 2064/4885 |
| US-20240228504-A1 | SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME | SLC10A1, NR1H4, SLC10A2 | KDM4E 1496/4885LMNA 1590/4885ADRA2C 3542/4885 |
| US-10941134-B2 | AMPK-activating heterocyclic compounds and methods for using the same | PRKAG1, PRKAG2, PRKAB1 | KDM4E 926/4885LMNA 2621/4885ADRA2C 1405/4885 |
| US-20230192671-A1 | COMPOUNDS FOR THE TREATMENT OF SARS | ACE2, ACE, SARS1 | KDM4E 3407/4885LMNA 2592/4885ADRA2C 1164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.